Supplemental material
Reviews
Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease
Omid Azimzadeha Federal Office for Radiation Protection (BfS), Section Radiation Biology, Neuherberg, GermanyCorrespondence[email protected]
https://orcid.org/0000-0001-8984-0388View further author information
https://orcid.org/0000-0001-8984-0388View further author information, Simone Moertla Federal Office for Radiation Protection (BfS), Section Radiation Biology, Neuherberg, Germanyhttps://orcid.org/0000-0003-0644-0878View further author information
https://orcid.org/0000-0003-0644-0878View further author information, Raghda Ramadanb Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgiumhttps://orcid.org/0000-0002-6826-7858View further author information
https://orcid.org/0000-0002-6826-7858View further author information, Bjorn Baseletb Institute for Environment, Health and Safety, Radiobiology Unit, Belgian Nuclear Research Centre (SCK CEN), Mol, Belgiumhttps://orcid.org/0000-0001-9840-2822View further author information
https://orcid.org/0000-0001-9840-2822View further author information, Evagelia C. Laiakisc Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA;d Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, USAhttps://orcid.org/0000-0002-4924-9013View further author information
https://orcid.org/0000-0002-4924-9013View further author information, , Danielle Beatone Canadian Nuclear Laboratories, Chalk River, Canadahttps://orcid.org/0000-0002-5764-5139View further author information
https://orcid.org/0000-0002-5764-5139View further author information, Jaana M. Hartikainenf School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, and Translational Cancer Research Area, University of Eastern Finland, Kuopio, Finlandhttps://orcid.org/0000-0001-8267-1905View further author information
https://orcid.org/0000-0001-8267-1905View further author information, Jan Christian Kaiserg Helmholtz Zentrum München, Institute of Radiation Medicine (HMGU-IRM), Neuherberg, Germanyhttps://orcid.org/0000-0003-0359-2251View further author information
https://orcid.org/0000-0003-0359-2251View further author information, Afshin Beheshtih KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, CA, USA;i Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USAhttps://orcid.org/0000-0003-4643-531XView further author information
https://orcid.org/0000-0003-4643-531XView further author information, Sisko Salomaaj Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finlandhttps://orcid.org/0000-0002-6866-655XView further author information
https://orcid.org/0000-0002-6866-655XView further author information, Vinita Chauhank Environmental Health Science Research Bureau, Health Canada, Ottawa, Canadahttps://orcid.org/0000-0002-4498-0915View further author information
https://orcid.org/0000-0002-4498-0915View further author information & Nobuyuki Hamadal Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), Komae, Japanhttps://orcid.org/0000-0003-2518-6131View further author information
https://orcid.org/0000-0003-2518-6131View further author information show allRelated Research Data
Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease
Source:
Taylor & Francis
Linking provided by
